A
Arvinas
ARVN
26.780
USD
-0.76
(-2.76%)
مغلق
حجم التداول
14,040
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
1,825,351,942
الأخبار
العنوان: Arvinas
القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.